Halozyme Therapeutics Inc. Common Stock vs Rio Tinto (ADR) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Rio Tinto (ADR) trades at $94.78 (market cap $150.89B). The key difference: Rio Tinto (ADR) is far larger — about 12× Halozyme Therapeutics Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 4.98% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Rio Tinto (ADR) for 10 Days on average.
| HALO | RIO | |
|---|---|---|
Market Cap | $12.58B | $150.89B |
Volume | 2,179,278 | 1,492,444 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $112.04 |
52-Week Low | $61.63 | $65.44 |
Typical Hold Time | 1 Days | 10 Days |
Enterprise Value | $14.49B | $164.24B |
Dividend Yield | — | 4.98% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →